HALO Growth 100 · Sector S2
Longevity & Healthspan
GLP-1 leaders, gene-editing platforms, diagnostics-at-scale, biopharma compounders. Demographics writes the demand curve.
Equal-weight — 1d —
Cap-weighted — 1d —
Momentum (drift) — 1d —
Constituents — in this sector
Composite Index — since inception (Dec 30, 2025)
Three weighting variants of the same constituent basket, rebased to 1,000 at inception. EW = ticker-equal-weight with quarterly drift. CW = cap-weighted (10% cap; below ten names the cap is infeasible, so the sub-index is equal weight by construction) with semi-annual rebalance. MW = drift-only (1/N at inception, market does the tilting between rebalances). Click a legend entry to toggle its line.
Constituents
Every HALO 100 constituent tagged into this sector. Click a column header to sort (best to worst). Click a row to open the stock detail page in a new tab.
| Ticker | Company | Region | Last | 1d | 1w | 1m | 3m | 6m | 1y | CCY |
|---|---|---|---|---|---|---|---|---|---|---|
| ILMN | Illumina | NAM | 206.45 | +2.57% | -6.86% | +7.02% | +24.21% | +78.65% | +116.20% | USD |
| GXI.DE | Gerresheimer | EUR | 28.22 | -2.62% | -0.21% | +4.91% | +15.37% | +55.48% | -33.19% | EUR |
| NTRA | Natera | NAM | 328.93 | +0.86% | +0.38% | +4.10% | +50.04% | +72.84% | +93.73% | USD |
| VRTX | Vertex Pharma | NAM | 515.44 | +0.17% | -7.62% | -1.96% | +15.82% | +7.80% | +32.66% | USD |
| REGN | Regeneron | NAM | 781.49 | -1.48% | -7.35% | -2.07% | +27.80% | +4.67% | +40.94% | USD |
| VKTX | Viking Therapeutics | NAM | 31.98 | -0.47% | -5.89% | -6.00% | +11.78% | -9.84% | +23.62% | USD |
| NVO | Novo Nordisk | EUR | 43.07 | -2.14% | -9.35% | -7.16% | -2.02% | +17.44% | -17.88% | USD |
| LLY | Eli Lilly | NAM | 1115.70 | -0.65% | -3.79% | -8.57% | -3.90% | +14.17% | +48.31% | USD |
| AMGN | Amgen | NAM | 377.35 | -1.34% | -15.03% | -9.33% | +6.58% | +2.60% | +37.40% | USD |
| ZEAL.CO | Zealand Pharma | EUR | 278.20 | -2.11% | -8.91% | -18.46% | -2.39% | +7.12% | -38.00% | DKK |